Perbak Capital Partners’s Arrowhead Research ARWR Stock Holding History

Perbak Capital Partners’s Portfolio ARWR Stock Details ARWR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-3,657	Closed	-$229K	–	29
2026 Q1	$229K	Buy	+3,657	New	+$231K	0.06%	281

Other funds holding ARWR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Perbak Capital Partners's ARWR Position: Q2 2026 in Review

Perbak Capital Partners sold out of Arrowhead Research (ARWR) in Q2 2026, closing a stake of 3,657 shares — an estimated $229K sold.

Perbak Capital Partners first reported a position in ARWR in Q1 2026 and held it in 1 quarter. The position peaked at $229K in Q1 2026. 500 funds tracked by Wall St. Rank hold ARWR as of Q2 2026.

Perbak Capital Partners reported no remaining Arrowhead Research position as of Q2 2026 after selling out during the quarter.
Perbak Capital Partners sold 3,657 Arrowhead Research shares in Q2 2026, an estimated $229K.
Perbak Capital Partners first reported a position in Arrowhead Research in Q1 2026 and held it in 1 quarter.
Perbak Capital Partners's Arrowhead Research position peaked at $229K in Q1 2026.
500 funds tracked by Wall St. Rank held Arrowhead Research as of Q2 2026.

Based on Perbak Capital Partners's 13F filing for Q2 2026.